Literature DB >> 31578995

A critique of the fragility index.

Tiago Machado1, Gonçalo S Duarte2, Nilza Gonçalves1, Joaquim J Ferreira3, João Costa4.   

Abstract

Year:  2019        PMID： 31578995     DOI： 10.1016/S1470-2045(19)30581-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  The ellipse of insignificance, a refined fragility index for ascertaining robustness of results in dichotomous outcome trials.

Authors:  David Robert Grimes
Journal:  Elife       Date:  2022-09-20       Impact factor: 8.713

2.  Assessing and visualizing fragility of clinical results with binary outcomes in R using the fragility package.

Authors:  Lifeng Lin; Haitao Chu
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

3.  Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them?

Authors:  Catarina M Dos Santos; Luísa Prada; Cláudio David; João Costa; Joaquim J Ferreira; Fausto J Pinto; Daniel Caldeira
Journal:  TH Open       Date:  2021-04-14

4.  Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations.

Authors:  Brooke E Wilson; Alexandra Desnoyers; Michelle B Nadler; Ariadna Tibau; Eitan Amir
Journal:  Cancer Med       Date:  2021-07-28       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.